We have read with interest the article by Etienne et al. in which the authors evaluate the value of blood cultures (BC) in patients with acute prostatitis (AP) (2). Since our group has a particular interest in these patients, which are included in a database, we would like to make some comments regarding the article.
Author's Reply
We are very pleased to be given the opportunity to reply to the comments made by Smithson et al. regarding our article "Should blood cultures be performed for patients with acute bacterial prostatitis?," published in the May 2010 issue of the Journal of Clinical Microbiology.
Their first comment raises the issue of the diagnostic criteria for acute prostatitis. We totally agree that the involvement of the prostate during male febrile urinary tract infection (UTI), though common, might be inconstant. However, to date, there is no routine investigation that would confirm that the prostate is free of infection. Moreover, UTI in men is associated with high rates of treatment failure and with persistent symptoms, such as chronic prostatitis/chronic pelvic pain syndrome (2, 3). Hence, the French guidelines recommend that all UTIs in males should be treated as prostatitis (1) . Second, the results observed by Smithson and al. are in complete agreement with our conclusions regarding the percentages of positive and contributive blood cultures. In our series, the pathogens isolated in contributive blood cultures (BC) exhibited high rates of intermediate susceptibility or resistance to amoxicillin for 11/14 (79%) patients, to amoxicillin-clavulanate for 10/14 (71%) patients, to cefotaxime for 3/14 (21%) patients, and to ciprofloxacin for 5/14 (36%) patients. For 3/14 (21%) patients, the pathogen isolated in BC was resistant to the probabilistic antibiotic treatment (ofloxacin for 1, ciprofloxacin for 1, and cefotaxime for 1 patient), and the treatment regimen was modified after the BC results were obtained. Although these results provide additional arguments for the recommendation of drawing BC, we did not report these results, due to the low number of patients. Lastly, we agree that the intensities of sepsis and positive BC might be confounding variables, both related to the prognosis of UTI in males. As suggested by Smithson et al., a prospective series, collecting the hemodynamic parameters at admission, and perhaps the inflammatory parameters as well, would help in determining better prognostic factors. Unfortunately, these parameters were not collected in our database. In conclusion, the BC withdrawn for untreated febrile patients appear to be useful primarily for microbiological diagnosis of UTI in males, either to identify the causative pathogens or to specify their susceptibility profile.
